APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,300,171 | -65.7% | 244,484 | -17.8% | 6.23% | -66.1% |
| Q2 2023 | $27,110,996 | +41.5% | 297,596 | +2.4% | 18.37% | +30.1% |
| Q1 2023 | $19,161,380 | +70.4% | 290,500 | +33.6% | 14.12% | +104.0% |
| Q4 2022 | $11,246,925 | -70.3% | 217,500 | -60.7% | 6.92% | -57.5% |
| Q3 2022 | $37,838,000 | +51.0% | 554,000 | 0.0% | 16.29% | +16.7% |
| Q2 2022 | $25,052,000 | -11.0% | 554,000 | 0.0% | 13.96% | +6.1% |
| Q1 2022 | $28,149,000 | +11.3% | 554,000 | +3.6% | 13.15% | +23.7% |
| Q4 2021 | $25,295,000 | +916.7% | 535,000 | +608.6% | 10.63% | +1110.9% |
| Q3 2021 | $2,488,000 | -75.5% | 75,500 | -53.0% | 0.88% | -78.3% |
| Q2 2021 | $10,144,000 | +108.9% | 160,500 | +41.8% | 4.05% | +131.5% |
| Q1 2021 | $4,856,000 | -49.2% | 113,161 | -32.3% | 1.75% | -32.7% |
| Q4 2020 | $9,555,000 | +89.6% | 167,054 | 0.0% | 2.60% | +89.9% |
| Q3 2020 | $5,040,000 | -18.8% | 167,054 | -12.1% | 1.37% | -23.6% |
| Q2 2020 | $6,205,000 | +10.5% | 190,000 | -9.3% | 1.79% | -34.1% |
| Q1 2020 | $5,613,000 | -2.2% | 209,500 | +11.7% | 2.72% | +91.4% |
| Q4 2019 | $5,741,000 | +55.3% | 187,500 | +11.6% | 1.42% | +116.1% |
| Q2 2018 | $3,696,000 | – | 168,000 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |